InflaRx N.V. Skyrocketed
Tue, Jul 26, 2022 at 06:58 PM
InflaRx N.V. (IFRX:NASDAQ) jumped higher at $1.92, representing a gain of 38.1%. On Tue, Jul 26, 2022, IFRX:NASDAQ hit a New 2-Week High of $1.92. The stock appeared on our News Catalysts scanner on Tue, Jul 26, 2022 at 08:03 AM in the 'BIOTECH' category. From Tue, Jul 12, 2022, the stock recorded 50.00% Up Days and 54.55% Green Days
About InflaRx N.V. (IFRX:NASDAQ)
InflaRx NV is a biopharmaceutical company. It discovers and develops potent and specific inhibitors of the complement activation factor known as C5a.
Top 10 Gainers:
- Ayala Pharmaceuticals, Inc. (AYLA:NASDAQ), 94.25%
- Pagaya Technologies Ltd. (PGY:NASDAQ), 73.11%
- Freight Technologies Inc Com (FRGT:NASDAQ), 67.57%
- Comera Life Sciences Holdings Inc. (CMRA:NASDAQ), 60.82%
- InflaRx N.V. (IFRX:NASDAQ), 38.13%
- HTG Molecular Diagnostics, Inc. (HTGM:NASDAQ), 30.08%
- AMTD Digital Inc. American Depositary Shares (every five of which represent two Class A) (HKD:NYSE), 28.42%
- Greenbrook TMS Inc. (GBNH:NASDAQ), 24.61%
- Bright Minds Biosciences Inc. (DRUG:NASDAQ), 22.16%
- Bellerophon Therapeutics, Inc. (BLPH:NASDAQ), 19.86%